Profile of Hepatitis B Sero Markers Among Blood Donors Attending Usmanu Danfodiyo University Teaching Hospital, Sokoto-Nigeria

Hussaini Mohammed Alhassan*; Saudetu Haruna Shinkafi; Ibrahim Yakubu; Hamisu Abdullahi; Ahmad Hamidu Marafa; Abdullahi Isiyaku; Mustapha Umar Kalgo

**Hussaini Mohammed Alhassan*, Saudetu Haruna Shinkafi, Ibrahim Yakubu, Hamisu Abdullahi, Ahmad Hamidu Marafa, Abdullahi Isiyaku and Mustapha Umar Kalgo**

Volume2-Issue5
Dates: Received: 2021-05-16 | Accepted: 2021-05-25 | Published: 2021-05-27
Pages: 412-417

Abstract

Introduction: Hepatitis B Virus (HBV) is a double-stranded circular DNA virus, it is one of the major blood transmissible infections. The prevalence of HBV is highest in sub-Saharan Africa and East Asia, where 5-20% of the adult population are infected. In Africa, up to 15 to 60% of the population are positive for at least one of the serological markers of HBV. This study aimed to determine the prevalence markers of HBV among prospective blood donors in Sokoto.

Materials/methods: About 170 blood donors were randomly recruited into this research study and 5ml of blood was aseptically collected from each of the research participants, the sample was screened for Hepatitis B virus, using a rapid step-wise HBV-5 panel immunoassay of Combo Cassette Manufactured by Lusys Laboratories Inc U.S.A. The HBV-5 is capable of detecting HBsAg, HBsAb, HBeAg, HBeAb and HBcAb simultaneously. The test component was opened from the notch, and the device was removed, 2-3 drops (60-90µl) plasma sample was added into the sample wells in the device. The result was read within 15 minutes.

Results: The prevalence rates of the markers are HBsAg 8(4.7%), HBeAg 1(0.6%), HBsAb 7(4.1%), HbeAb 8(4.7%), and HBcAb 9(5.3%). Donors aged (20-30) years had the highest prevalence rate of HBV infection compared to other age groups. Male blood donors had higher seropositivity for the five markers than their female counterpart. The prevalence of HBV markers was high among the First time donors (non-vaccinated donors) who have a higher prevalence than other donors (vaccinated donors).

Conclusion: This study has shown that screening for HBsAg alone may not be sufficient for the diagnosis of hepatitis B virus infection, and thus other markers should be included in the routine screening.

FullText HTML FullText PDF DOI: 10.37871/jbres1251

Certificate of Publication

Copyright

How to cite this article

Alhassan HM, Shinkafi SH, Yakubu I, Abdullahi H, Marafa AH, Isiyaku A, Kalgo MU. Profile of Hepatitis B Sero Markers Among Blood Donors Attending Usmanu Danfodiyo University Teaching Hospital, Sokoto-Nigeria. J Biomed Res Environ Sci. 2021 May 27; 2(5): 412-417. doi: 10.37871/jbres1251, Article ID: jbres1251

Subject area(s)

Immunotherapy

Immunology

References

Seeger C, Zoulium F, Mason WS. Hepadnaviruses- 5th Edition. Journal of Virology Philadelphia. 2013;24:321-332.
WHO. Hepatitis B. 2011. https://bit.ly/3uosTbe
Lee WM. Hepatitis B virus infection. N Engl J Med. 1997 Dec 11;337(24):1733-45. doi: 10.1056/NEJM199712113372406. PMID: 9392700.
Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open. 2014 Nov 11;4(11):e005889. doi: 10.1136/bmjopen-2014-005889. PMID: 25387757; PMCID: PMC4244481.
WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection.
Tao I, Compaoré TR, Diarra B, Djigma F, Zohoncon TM, Assih M, Ouermi D, Pietra V, Karou SD, Simpore J. Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso. Hepat Res Treat. 2014;2014:781843. doi: 10.1155/2014/781843. Epub 2014 Aug 5. PMID: 25161770; PMCID: PMC4138785.
Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. Niger J Clin Pract. 2015 Mar-Apr;18(2):163-72. doi: 10.4103/1119-3077.151035. PMID: 25665986.
WHO. The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: A Systematic Review, World Health Organization, Department of Immunization, Vaccine and Biologicals. 2013.
Olaso SO, Odaibo GN. Alfa-fetoprotein, HCV and HBV infections in Nigerian patients with primary hepatocellular carcinoma. Nigeria Medical Practices. 2007;51:33-35.
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006 Oct;45(4):529-38. doi: 10.1016/j.jhep.2006.05.013. Epub 2006 Jun 23. PMID: 16879891.
Barker LF, Shulman NR, Murray R, Hirschman RJ, Ratner F, Diefenbach WC, Geller HM. Transmission of serum hepatitis. 1970. JAMA. 1996 Sep 11;276(10):841-4. PMID: 8769597.
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004 Mar;11(2):97-107. doi: 10.1046/j.1365-2893.2003.00487.x. PMID: 14996343.
Energy YE. Overview on Hepatitis B virus. Nature and Science. 2011;9:31-36.
Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J. 2011 Mar 4;8:96. doi: 10.1186/1743-422X-8-96. PMID: 21375724; PMCID: PMC3060146.
Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Hum Antibodies. 2011;20(3-4):77-82. doi: 10.3233/HAB-2011-0242. PMID: 22129677.
Japhet MO, Adesina OA, Donbraye E, Adewumi M. Hepatitis B Core IgM antibody (anti-HBc IgM) among hepatitis B surface (HBsAg) negative blood donors in Nigeria. Virology Journal. 2011;8:513-551.
National Population Commission. Nigerian Population Census. Abuja-Nigeria. 2009.
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013 Apr;35(2):121-6. doi: 10.4103/0253-7176.116232. PMID: 24049221; PMCID: PMC3775042.
Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J. 2011 Nov 10;8:513. doi: 10.1186/1743-422X-8-513. PMID: 22074048; PMCID: PMC3239416.
Soldan K, Ramsay M, Collins M. Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database. BMJ. 1999 Jan 9;318(7176):95. doi: 10.1136/bmj.318.7176.95. PMID: 9880282; PMCID: PMC27683.
Kleinman SH, Busch MP. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling. Baillieres Clinical Haematology. 2010;13(4):631-649.
Gutiérrez-García ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011 Mar 28;17(12):1538-42. doi: 10.3748/wjg.v17.i12.1538. PMID: 21472117; PMCID: PMC3070122.
Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica. 2007 Dec;92(12):1664-70. doi: 10.3324/haematol.11224. PMID: 18055990.
Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol. 2009 Mar;81(3):406-12. doi: 10.1002/jmv.21418. PMID: 19152393.
Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol. 2009 Mar;81(3):406-12. doi: 10.1002/jmv.21418. PMID: 19152393.
Lawal OA, Bakarey AS, Uche LN, Udeze AO, Okonko IO. HBV infection among intending blood donors who incidentally tested positive for HIV antibodies in two blood banks in Ibadan, Nigeria. World Applied Science Journal. 2009;1(2):97-107.
Luka SA, Ibrahim MB, IIiya SN. Seroprevalence of hepatitis B surface antigen among pregnant women attending Ahmadu University Teaching Hospital, Zaria, Nigeria. Nigerian Journal of Parasitology. 2008;29(1): 38-41. https://tinyurl.com/b7ez63k
Buseri FI, Muhibi MA, Jeremiah ZA. Seroepidemiology of transfusion transmissible infectious diseases among blood donors in Osogbo, South-West Nigeria. Blood Transfusion. 2009;7(4):293-299.
Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz. 2005 Feb;100(1):13-6. doi: 10.1590/s0074-02762005000100002. Epub 2005 Apr 12. PMID: 15867956.
Mehmet D, Meliksah E, Serif Y, et al. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Japanese Journal of Infectious Diseases. 2005 Feb;58(1):15-19.
Balogun TM, Durojaiye IO, Sagoe A, Emmanuel S. Seroepidemiology of hepatitis-B surface antigenaemia in HIV positive patients. West Afr J Med. 2010 May-Jun;29(3):169-73. doi: 10.4314/wajm.v29i3.68215. PMID: 20665460.
Ugwuja E, Ugwu N. Seroprevalence of Hepatitis B Surface Antigen and Liver Function Tests among Adolescents in Abakaliki, South Eastern Nigeria. The Internet Journal of Tropical Medicine. 2010;6(1):5580-5297.
Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, Sack U. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010 May 10;10:111. doi: 10.1186/1471-2334-10-111. PMID: 20459703; PMCID: PMC2881920.